# Govt restricts two-ingredient FDCs for children under four 2026-08-22T07:56:46+00:00 | Governance | Indian Opinion Desk Corroboration: 3 independent outlets The government has restricted the manufacture, sale and distribution of all fixed dose combinations (FDCs) containing Chlorpheniramine Maleate and Phenylephrine Hydrochloride for children below four years of age. The notification, issued under Section 26A of the Drugs and Cosmetics Act, 1940, mandates a clear warning on labels, package inserts and promotional literature that these medicines shall not be used in children below four. The decision follows recommendations by an expert committee and the Drugs Technical Advisory Board (DTAB). The government noted that such combinations may pose risks to young children and that safer alternatives are available. The restriction extends an earlier April 15, 2025 notification that covered only certain FDCs with the same two ingredients. The Hindu, Livemint and Assam Tribune all report the ban as a straightforward health measure, with no significant differences in framing. Assam Tribune additionally notes that the Supreme Court had earlier called for a comprehensive review of FDCs, which led to the DTAB forming an expert committee. ## Indian Opinion Analysis All three sources report the restriction as a factual regulatory action with no editorial slant. The Hindu leads with the health-safety justification and mentions the expert committee and DTAB prominently. Livemint adds context about a broader ban on 16 FDCs in June 2026 but frames it as background. Assam Tribune uniquely mentions the Supreme Court's role in prompting the review. No source presents criticism or alternative views. The coverage is uniform straight reporting, the key takeaway is that regulators are systematically tightening paediatric drug safety, with this notification closing a loophole left by the April 2025 order. Watch for further FDC restrictions as the expert committee continues its review. ## Coverage Coverage: 3 sources, 3 neutral - thehindu.com (neutral report) Leads with health safety, no editorialising - livemint.com (neutral report) Straight news with added context of June ban - assamtribune.com (neutral report) Includes SC review background, otherwise factual This story was synthesised by AI from the 3 sources linked above. Updated: this story now draws on 3 sources. Last updated 2026-08-22T16:51:12+00:00. Tags: Chlorpheniramine Maleate, drugs and cosmetics act, Drugs Technical Advisory Board Canonical: https://indianopinion.org/government-restricts-cold-medicine-use-for-children-under-four/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/government-restricts-cold-medicine-use-for-children-under-four/#story-in-brief How this brief was made: an AI model read the reports linked above and wrote this summary and analysis, which were published automatically. Published briefs are sampled every hour by an automated quality check; the editor verifies its findings and approves corrections, and corrected briefs carry a dated correction line. Stance labels are editorial classifications of how each outlet framed this story, assigned by the same model, not ratings of the outlets. We do no original reporting. Methodology: https://indianopinion.org/ai-use-policy/